Gena Wang PhD, CFA, is an equity research analyst covering U.S. Small & Mid Cap Biotechnology and has been ranked top 3 in the sector by Institutional Investor since 2018 (except 2020 RU). She has sell-side experience since 2009 and before her career on Wall Street had extensive scientific research experience and published numerous peer-reviewed papers. Gena was a Post-Doctoral Researcher in Molecular Neuro-oncology at Rockefeller University and received her PhD in Molecular Biology from SUNY Downstate Medical Center.